The Biology and Genetics of NBS
At a Glance
Nijmegen breakage syndrome is caused by disease-causing changes in both copies of the NBN gene, which disrupt nibrin and DNA repair. Genetic testing confirms the diagnosis and can clarify inheritance and carrier risks for relatives.
Understanding the biological “why” behind Nijmegen Breakage Syndrome (NBS) can help you navigate the medical reports and specialized care your child needs. NBS is not caused by something that happened during pregnancy; it is a fundamental difference in how your child’s cells manage their DNA.
The Repair Crew: Nibrin and the MRN Complex
Inside every cell, DNA is constantly being damaged by normal biological processes or environmental factors. One of the most serious types of damage is a double-strand break, where both strands of the DNA “ladder” are severed [1].
To fix these breaks, the body uses a specialized repair crew called the MRN complex [2]. This complex is made of three proteins: MRE11, RAD50, and nibrin (the protein produced by the NBN gene) [1][3].
- The Sensors: The MRN complex acts as a first responder. It rushes to the site of a DNA break, “clamps” onto the broken ends, and holds them together so they can be repaired [1][4].
- The Signal: Nibrin works with the other proteins to recruit and activate a “master controller” protein called ATM [3]. Once activated, ATM sends out a signal that tells the cell to stop growing and focus entirely on the repair [3][5].
In children with NBS, the nibrin protein is deficient or severely impaired. This means the repair crew cannot “bridge” the broken DNA properly, and the signal to fix the damage is impaired [2][6]. (Note that some genetic variants, called hypomorphic variants, leave a small amount of residual nibrin function). This leads to chromosomal instability, where cells continue to grow with broken or scrambled DNA, eventually leading to the health challenges seen in NBS [7][8].
The Slavic Founder Effect
While NBS can affect people of any background, it is most common in people with Slavic ancestry (such as those from Poland, Ukraine, Russia, or the Czech Republic) [9]. This is due to a specific mutation known as the Slavic founder mutation, or c.657_661del5 [10].
This mutation is a “five-base-pair deletion”—a tiny piece of missing code in the NBN gene [11]. It is called a “founder” mutation because it originated in a single individual hundreds of years ago and was passed down through generations within the Slavic population [9]. In some specific Eastern European regions, as many as 1 in 100 people are carriers of this specific mutation [10].
How NBS is Inherited
NBS is an autosomal recessive condition [12]. This means:
- Carriers: Each parent usually carries one working copy of the NBN gene and one non-working (mutated) copy. Carriers typically have no NBS symptoms, though families should discuss the implications of their specific variant for adult relatives with a genetic counselor [10].
- The 25% Rule: When two carriers have a child, there is a 25% (1 in 4) chance in each pregnancy that the child will inherit the mutated copy from both parents. When this happens, the child does not have a working “manual” for making nibrin, resulting in NBS [11].
Distinguishing NBS from “Look-Alikes”
Because several genetic conditions involve DNA repair and cause similar symptoms, doctors must carefully distinguish NBS from its “look-alikes.”
| Feature | Nijmegen Breakage (NBS) | Ataxia-Telangiectasia (A-T) | Fanconi Anemia (FA) | Bloom Syndrome |
|---|---|---|---|---|
| Primary Gene | NBN (Nibrin) [12] | ATM [13] | Multiple (FANCA, etc.) [8] | BLM [14] |
| Head Size | Microcephaly (small head) usually present at birth [12] | Usually normal at birth [13] | May have microcephaly [8] | Usually small head [14] |
| Movement | No specific movement issues [12] | Ataxia (progressive balance/coordination issues) [13] | No specific movement issues | No specific movement issues |
| Skin/Eyes | Distinctive facial features [12] | Telangiectasia (tiny visible red “spider” veins) [13] | Skin spots (cafe-au-lait) [8] | Sun-sensitive rash [14] |
| Cancer Risk | Very high risk of Lymphoma [15] | High risk of Lymphoma and Leukemia [13] | High risk of Leukemia and solid tumors [8] | Very high risk of many cancer types [14] |
The Path to a Definitive Diagnosis
A diagnosis of NBS is evaluated by a clinical geneticist and confirmed through molecular genetic testing [16]. A definitive report should show:
- Biallelic Pathogenic Variants: This means “pathogenic” (disease-causing) mutations were found in both copies of the NBN gene [16][12]. A variant of uncertain significance does not confirm the disease.
- In Trans Confirmation: Geneticists often test the parents to confirm that one mutation came from each parent (this is called being in trans) [17]. This proves the mutations are on separate chromosomes.
- Advanced Testing: If standard sequencing only finds one mutation but the child has clear symptoms, they may perform a specialized test (like MLPA) to look for larger “missing pieces” or copy-number changes of the gene [18].
- Functional Testing (Optional): If the genetic results require further interpretation, doctors may use a radiosensitivity assay [19]. They expose a small sample of the child’s cells to radiation in a lab (never by exposing the child); if the cells cannot repair themselves, it provides functional support for the diagnosis [19][17].
Common questions in this guide
What causes Nijmegen breakage syndrome?
How is NBS inherited, and what is the chance in another pregnancy?
What is the Slavic founder mutation in NBS?
What genetic results confirm Nijmegen breakage syndrome?
What happens if genetic testing finds only one NBN mutation?
How do doctors distinguish NBS from similar DNA-repair disorders?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does our child have the 'Slavic founder' mutation (c.657_661del5) on both copies of the gene, or are there two different mutations?
- 2.Does the genetic report confirm that the two mutations are 'in trans' (on separate chromosomes), and have we as parents been tested to confirm our carrier status?
- 3.If only one mutation was found, did the lab perform 'copy number' testing or 'MLPA' to look for a second, hidden deletion?
- 4.Based on our child's specific mutations, do you expect any residual nibrin protein function (a 'hypomorphic' state)?
- 5.How were other look-alike conditions, like Ataxia-Telangiectasia or Fanconi Anemia, ruled out in our case?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (19)
- 1
Structural basis for DNA break sensing by human MRE11-RAD50-NBS1 and its regulation by telomeric factor TRF2.
Fan Y, Kuybu F, Cui H, et al.
Nature communications 2025; (16(1)):8320 doi:10.1038/s41467-025-64082-x.
PMID: 40968163 - 2
NBS1 promotes the endonuclease activity of the MRE11-RAD50 complex by sensing CtIP phosphorylation.
Anand R, Jasrotia A, Bundschuh D, et al.
The EMBO journal 2019; (38(7)) doi:10.15252/embj.2018101005.
PMID: 30787182 - 3
Structure of the human ATM kinase and mechanism of Nbs1 binding.
Warren C, Pavletich NP
eLife 2022; (11()).
PMID: 35076389 - 4
Xrs2/NBS1 promote end-bridging activity of the MRE11-RAD50 complex.
Möller C, Sharma R, Öz R, et al.
Biochemical and biophysical research communications 2024; (695()):149464 doi:10.1016/j.bbrc.2023.149464.
PMID: 38217957 - 5
ATM-Dependent Phosphorylation of All Three Members of the MRN Complex: From Sensor to Adaptor.
Lavin MF, Kozlov S, Gatei M, Kijas AW
Biomolecules 2015; (5(4)):2877-902 doi:10.3390/biom5042877.
PMID: 26512707 - 6
Suppression of NBS1 Upregulates CyclinB to Induce Olaparib Sensitivity in Ovarian Cancer.
Zhong A, Cheng CS, Lu RQ, Guo L
Technology in cancer research & treatment 2024; (23()):15330338231212085 doi:10.1177/15330338231212085.
PMID: 38192153 - 7
Evidence for a pre-malignant cell line in a skin biopsy from a patient with Nijmegen breakage syndrome.
Habib R, Neitzel H, Ernst A, et al.
Molecular cytogenetics 2018; (11()):17 doi:10.1186/s13039-018-0364-6.
PMID: 29445421 - 8
Chromosome instability syndromes.
Taylor AMR, Rothblum-Oviatt C, Ellis NA, et al.
Nature reviews. Disease primers 2019; (5(1)):64 doi:10.1038/s41572-019-0113-0.
PMID: 31537806 - 9
The Slavic NBN Founder Mutation: A Role for Reproductive Fitness?
Seemanova E, Varon R, Vejvalka J, et al.
PloS one 2016; (11(12)):e0167984 doi:10.1371/journal.pone.0167984.
PMID: 27936167 - 10
Geographical Distribution, Incidence, Malignancies, and Outcome of 136 Eastern Slavic Patients With Nijmegen Breakage Syndrome and NBN Founder Variant c.657_661del5.
Sharapova SO, Pashchenko OE, Bondarenko AV, et al.
Frontiers in immunology 2020; (11()):602482 doi:10.3389/fimmu.2020.602482.
PMID: 33488600 - 11
T-lymphoblastic leukemia/lymphoma in macedonian patients with Nijmegen breakage syndrome.
Kocheva SA, Martinova K, Antevska-Trajkova Z, et al.
Balkan journal of medical genetics : BJMG 2016; (19(1)):91-94 doi:10.1515/bjmg-2016-0012.
PMID: 27785413 - 12
Nijmegen breakage syndrome: case report and review of literature.
Hasbaoui BE, Elyajouri A, Abilkassem R, Agadr A
The Pan African medical journal 2020; (35()):85 doi:10.11604/pamj.2020.35.85.14746.
PMID: 32537088 - 13
Two novel variants in the ATM gene causing ataxia-telangiectasia, including a duplication of 90 kb: Utility of targeted next-generation sequencing in detection of copy number variation.
Martin-Rodriguez S, Calvo-Ferrer A, Ortega-Unanue N, et al.
Annals of human genetics 2019; (83(4)):266-273 doi:10.1111/ahg.12312.
PMID: 30888062 - 14
DNA Repair Syndromes and Cancer: Insights Into Genetics and Phenotype Patterns.
Sharma R, Lewis S, Wlodarski MW
Frontiers in pediatrics 2020; (8()):570084 doi:10.3389/fped.2020.570084.
PMID: 33194896 - 15
Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome.
Wolska-Kusnierz B, Pastorczak A, Fendler W, et al.
Clinical cancer research : an official journal of the American Association for Cancer Research 2021; (27(2)):575-584 doi:10.1158/1078-0432.CCR-20-2574.
PMID: 33082212 - 16
Attenuated Form of Nijmegen Breakage Syndrome: Case Report of the Oldest Patient.
Gangal SK, Sezer A, Yazici O, Erdem HB
American journal of medical genetics. Part A 2025; (197(11)):e64170 doi:10.1002/ajmg.a.64170.
PMID: 40605475 - 17
Adulthood diagnosis of Nijmegen breakage syndrome in twins with antibody deficiency clinical presentation.
González MAM, Rodríguez-Sainz C, Cardenas PP, et al.
Clinical immunology (Orlando, Fla.) 2026; (286()):110732 doi:10.1016/j.clim.2026.110732.
PMID: 42297123 - 18
Utility of DNA, RNA, Protein, and Functional Approaches to Solve Cryptic Immunodeficiencies.
Cousin MA, Smith MJ, Sigafoos AN, et al.
Journal of clinical immunology 2018; (38(3)):307-319 doi:10.1007/s10875-018-0499-6.
PMID: 29671115 - 19
Nijmegen breakage syndrome detected by newborn screening for T cell receptor excision circles (TRECs).
Patel JP, Puck JM, Srinivasan R, et al.
Journal of clinical immunology 2015; (35(2)):227-33 doi:10.1007/s10875-015-0136-6.
PMID: 25677497
This page is for informational purposes only and does not constitute medical advice. A clinical geneticist or genetic counselor should interpret your child’s NBN results and guide decisions about family testing.
Get notified when new evidence is published on Nijmegen breakage syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.